Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,315.00    0.00 (0.00%)
Bid:
2,315.00
Ask:
2,320.00
Spread: 5.00 (0.216%)
Market Cap: £3.14b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Annual Overview from QuotedData

15 May 2025 11:43

RNS Number : 8567I
RIT Capital Partners PLC
15 May 2025
 

RIT Capital Partners - Annual overview from QuotedData

15th May 2025

Riding out the tariff storm

Uncertainty levels have increased across global markets, with Trump's tariffs throwing up an additional source of risk. RIT Capital Partners' (RIT's) diversified portfolio (spread across asset classes, sectors and geographies) and stringent risk controls put it in a unique position to weather the storm. Leveraging off its manager's investment skillset and unparalleled access to specialist fund managers, the trust's portfolio has been constructed with the aim of performing well across market cycles.

Risk controls, such as downside protection strategies, help its manager take a long-term view and lean into investment trends with confidence. One such trend is a broadening of returns away from technology titans to undervalued sectors such as small- and mid-cap stocks, quality stocks (companies with strong balance sheets, consistent earnings, and good corporate governance), Japan, and China - a theme that started to play out before the tariffs shenanigans but could be accelerated because of it. Although it is continuing to reduce its private investments exposure, the company has made some potentially game changing investments, including in SpaceX, which could prove a source of superior returns for many years.

Full Research:

https://quoteddata.com/research/rit-capital-partners-riding-out-the-tariff-storm-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note RIT Capital Partners Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGPUUCAUPAGUA
Date   Source Headline
11th Mar 20217:00 amRNSHolding(s) in Company
5th Mar 20219:38 amRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSAnnual Financial Report
26th Feb 20218:10 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSHolding(s) in Company
15th Feb 20217:00 amRNSNet Asset Value(s)
4th Feb 20217:00 amRNSNet Asset Value(s)
23rd Dec 20207:00 amRNSTransaction in Own Shares
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSTransaction in Own Shares
15th Dec 20207:00 amRNSTransaction in Own Shares
14th Dec 20207:00 amRNSNet Asset Value(s)
4th Dec 20205:36 pmRNSDirector/PDMR Shareholding
20th Nov 20204:04 pmRNSDirector/PDMR Shareholding
17th Nov 20205:27 pmRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSNet Asset Value(s)
2nd Nov 20207:30 amRNSTransaction in Own Shares
30th Oct 20207:30 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value(s)
15th Sep 20207:00 amRNSNet Asset Value(s)
17th Aug 20207:00 amRNSNet Asset Value(s)
4th Aug 20207:00 amRNSHalf-year Report
21st Jul 20207:00 amRNSNet Asset Value(s)
10th Jul 20205:25 pmRNSCommittee changes
18th Jun 20203:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSNet Asset Value(s)
26th May 20205:15 pmRNSResult of AGM
18th May 20207:00 amRNSNet Asset Value(s)
7th May 20206:02 pmRNSDirector/PDMR Shareholding
30th Apr 202011:12 amRNSDisclosure of Rights Attached To Ordinary Shares
21st Apr 202010:05 amRNSNotice of AGM
17th Apr 20207:00 amRNSNet Asset Value(s)
6th Apr 20205:41 pmRNSDirector/PDMR Shareholding
1st Apr 20204:06 pmRNSDirector/PDMR Shareholding
24th Mar 20205:16 pmRNSAnnual General Meeting 2020 postponement
16th Mar 20207:00 amRNSNet Asset Value(s)
11th Mar 20203:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAnnual Financial Report
17th Feb 20207:00 amRNSNet Asset Value(s)
5th Feb 20207:00 amRNSNet Asset Value(s)
7th Jan 20204:19 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.